Sunmi Shin

Title: Sunmi Shin: Innovator in Pharmaceutical Chemistry

Introduction

Sunmi Shin is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. With a total of 3 patents to his name, Shin is recognized for his work in creating effective treatments for various health conditions.

Latest Patents

One of Sunmi Shin's latest patents involves the creation of salt forms of an organic compound. This patent discloses a salt compound of 4-(2-((4-bromophenyl)thio)acetamido)-1-phenethyl-1H-pyrazole-3-carboxylic acid. The patent also outlines methods for producing the salt compound and its formulations into dosage forms for clinical use. Another significant patent focuses on mutual prodrugs comprising short chain fatty acids and zebularine or 1'-cyano-cytarabine for cancer treatment. This invention provides methods for the production of these mutual prodrugs, as well as their administration and pharmaceutical compositions. The mutual prodrugs are designed to serve as therapeutic agents for treating cancer diseases and conditions.

Career Highlights

Sunmi Shin is currently associated with Kainos Medicine Inc., where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, particularly in the area of cancer treatment.

Collaborations

Shin collaborates with talented individuals in his field, including Hyangmi Kim and Su-Sung Oh. These collaborations enhance the innovative potential of his projects and contribute to the advancement of pharmaceutical research.

Conclusion

Sunmi Shin's contributions to pharmaceutical chemistry through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for new treatments and advancements in medical science.